Less is more in the case of this cancer treatment. The most common form of cancer among men in the US, after skin cancer, ...

CHICAGO -- Patients with advanced prostate cancer treated with enzalutamide (Xtandi) had a significantly greater decline in ...

Prostate cancer is one of the top diagnoses for men with cancer, but early stages are tough to detect.

Researchers with the James P. Allison Institute at The University of Texas MD Anderson Cancer Center have discovered a new ...

If you have prostate cancer, your health care provider may have told you about a medicine called Nubeqa (darolutamide). The FDA approved Nubeqa in 2019. It is commonly used to treat prostate cancer ...

Prostate cancer is the most commonly diagnosed cancer in the UK, with more than 63,000 new cases each year. Yet for many men, understanding their treatment options remains far from straightforward ...

A new study has highlighted a significant knowledge gap among patients about repeat radiotherapy (reirradiation) as a treatment option for recurrent prostate cancer ...

Recently, the research group led by Dr. Dechao Feng, Lecturer at University College London (UCL) and Distinguished Research ...

Every year, hundreds of thousands of men receive a prostate cancer diagnosis and immediately face a decision that medical ...